Notice2023-21567
Advisory Committee to the Director, Centers for Disease Control and Prevention
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 2, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This is a hybrid meeting, accessible both in person and virtually (webcast live via the World Wide Web). It is open to the public and limited only by the space available. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 189 (Monday, October 2, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Pages 67753-67754]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-21567]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0082]
Advisory Committee to the Director, Centers for Disease Control
and Prevention
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting of
the Advisory Committee to the Director, Centers for Disease Control and
Prevention (ACD, CDC). This is a hybrid meeting, accessible both in
person and virtually (webcast live via the World Wide Web). It is open
to the public and limited only by the space available. Time will be
available for public comment.
DATES: The meeting will be held on November 14, 2023, from 9:00 a.m. to
4:00 p.m., EST (times subject to change).
Written comments must be received on or before October 27, 2023.
ADDRESSES:
Meeting address: CDC Roybal Campus, Building 19, Auditorium B3,
1600 Clifton Road NE, Atlanta, Georgia 30329-4027.
Please note that the meeting location, the CDC Roybal Campus, is a
federal facility and in-person access is limited to United States
citizens unless prior authorizations, taking up to 30 to 60 days, have
been made. Visitors must follow all directions for access to CDC
facilities. Directions for visitors to CDC, including safety
requirements related to COVID-19; are available at <a href="https://www.cdc.gov/screening/visitors.html">https://www.cdc.gov/screening/visitors.html</a>.
Registration: You must register to attend this meeting in person.
If you wish to attend in person, please submit a request by email to
<a href="/cdn-cgi/l/email-protection#efaeacab869d8a8c9b809daf8c8b8cc1888099"><span class="__cf_email__" data-cfemail="87c6c4c3eef5e2e4f3e8f5c7e4e3e4a9e0e8f1">[email protected]</span></a> or by telephone at (404) 345-1039 at least 5
business days in advance of the meeting. No registration is required to
view the meeting via the World Wide Web. Information for accessing the
webcast will be available at <a href="https://www.cdc.gov/about/advisory-committee-director/">https://www.cdc.gov/about/advisory-committee-director/</a>.
Written comments: You may submit comments, identified by Docket No.
CDC-2023-0082, by either of the methods listed below. Do not submit
comments for the docket by email. CDC does not accept comments for the
docket by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Bridget Richards, MPH, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia
30329-4027. Attn: Docket No. CDC-2023-0082.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Written comments received in advance of the meeting will be included in
the official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Bridget Richards, MPH, Office of the
Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027;
Telephone: (404) 345-1039; Email: <a href="/cdn-cgi/l/email-protection#743537301d061117001b06341710175a131b02"><span class="__cf_email__" data-cfemail="dc9d9f98b5aeb9bfa8b3ae9cbfb8bff2bbb3aa">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director, CDC, shall (1)
make recommendations to the Director regarding ways to prioritize the
activities of the agency in alignment with the CDC Strategic Plan
required under section 305(c); H.R. 2617-1252; (2) advise on ways to
achieve or improve performance metrics in relation to the CDC Strategic
Plan, and other relevant metrics, as appropriate; (3) provide advice
and recommendations on the development of the Strategic Plan, and any
subsequent updates, as appropriate; (4) advise on grant, cooperative
agreements, contracts, or other transactions, as applicable; (5)
provide other advice to the Director, as requested, to fulfill duties
under sections 301 and 311; and (6) appoint subcommittees. The
Committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters to be Considered: The agenda will include an introduction
of the new CDC Director, Dr. Mandy Cohen, and a discussion regarding
agency updates and priorities. The agenda also includes updates on the
progress made to date on the health equity, laboratory, and data and
surveillance recommendation; discussion and vote on the Laboratory
Workgroup final recommendations; and discussion and votes to sunset the
Health Equity and Laboratory workgroups due to completion of their
terms of reference. CDC's Senior Advisor for Health Strategy will
present on supporting healthy families, and a Senior Counselor to the
CDC Director will present on COVID-19 recission. Agenda items are
subject to change as priorities dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments on October 2, 2023 through October 27, 2023.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other
[[Page 67754]]
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease
Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-21567 Filed 9-29-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 2, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.